​​​​​​​The co-director of UHN's Krembil Brain Institute and Senior Scientist at the Princess Margaret Cancer Centre shares her fascinating findings that have led to a new way of understanding the biology of meningiomas, skull base tumors.

Air Date: December 5, 2023 | Length: 01:05:10 | Download the transcript 

Apple Podcast logo  
Listen on Google Play Music  
Podbean logo  
Spotify logo  
Howard Abrams

Episode Description

UHN's Dr. Gelareh Zadeh sits down to talk about her pioneering research of meningiomas – or skull base tumors, and her discovery of the biology – or makeup – of these meningiomas. She also speaks to her amazing career journey, starting with her family's decision to escape their homeland in Iran following the Iranian Revolution, landing in Winnipeg on a cold Boxing Day in 1988. From there, she tracks her successful professional trajectory, and meteoric rise as a medical leader - including her appointment as Chair of Neurosurgery at the University of Toronto in 2020 - the first woman ever in Canada to lead a university neurosurgical program.

About Dr. Zadeh

Follow Dr. Zadeh on X

Dr. Zadeh has an MD, PhD, FRCS(C), FAANS

She is Head, Division of Neurosurgery, Toronto Western Hospital, Sprott Department of Surgery, UHN; co-director Krembil Brain Institute, UHN; Senior Scientist, Princess Margaret Cancer Centre, where she runs a translational research program at MacFeeters-Hamilton Neuro-oncology Program and holds the Wilkins Family Brain Tumor Research Chair.

Dr. Zadeh has a dedicated neuro-oncology and skull base practice, which includes a number of multidisciplinary specialized programs including a skull base clinic, brain metastases, pituitary clinic, and neurofibromatosis clinics.

She also has an active research laboratory focusing on integrated multi-platform molecular analysis of brain tumors, together with a focus on understanding molecular response to targeted therapies, such as anti-angiogenesis and metabolic inhibitors.

She had held a number of leadership roles in organized neuro-oncology and neurosurgery societies, nationally and internationally. To highlight a few she has held numerous leadership roles in Society of Neuro-Oncology (SNO): Chair of the International Committee, Scientific Chair of the Annual Scientific Program, Treasurer, Vice President and President, with currently 2022/23 being the immediate Past President of Society. She has served as the Chair of Neuro-oncology Committee and presently the Chair of Women in Neurosurgery at the World Federation of Neurological Surgeons. She is the current Chair of Education Committee of the Tumor Section of AANs. Leveraging her experience in these positions she has found and leads the International Consortium on Meningiomas (ICOM).

She is the Editor-in-Chief of Neuro-Oncology Advances, open-access journal of SNO and European Association of Neuro-Oncology.

Dr. Zadeh has also trained a number of neurosurgery residents, graduate students and fellows in a wide range of expertise in neurosurgery and research.

Back to Top